The Biotech Tea
SubstackA weekly biotech newsletter that pairs short roundups of recent research, company news and FDA or NIH policy with occasional longer explainers, such as a CRISPR pathogen-therapy profile and a recurring glossary term. Its paid-subscriber format means some issues are only partly visible to free readers.